explore -WSS

explore

author：leisure time 2025-09-27 21:55:15 - browse：85

STAT Q&A — Paul Matteis (right), in 2017 with then-colleagues Seamus Fernandez (far left) Geoffrey Porges. Alex Hogan/STAT

NEW YORK — Is biotech having a renaissance in neuroscience? Can we solve the placebo effect? And what’s going to happen next year?

Paul Matteis, co-head of biotech research at Stifel, sat down with STAT at the firm’s annual health care conference here to field those questions and opine on how management teams can walk the delicate balance between hype and sandbagging. This transcript has been edited for length and clarity.

One thing I’ve been hearing lately is that biotech has entered a sort of renaissance in neuroscience. Do you agree with that?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： FDA approves Eli Lilly ulcerative colitis treatment Omvoh

entertainment

WSS

Medtronic CEO on promising devices for diabetes, hypertension

Emergency medicine has repudiated 'excited delirium.' Now what?

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Make 'food is medicine' a key part of White House nutrition meeting

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Senate panel to vote on hospitals, PBMs, prisoner care

explore

explore

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: What happened with Sarepta's Duchenne data

Guidelines to prevent youth baseball injuries need more muscle

Eli Lilly to pay $200M for Beam’s stake in gene

After affirmative action ruling, medical educators look to 'holistic review'

STAT Wunderkinds: Ruey Hu's digital tools for parsing research

Hepatitis C has a cure — but many Americans still lack access to it

Meta looks to target Twitter with a rival app called Threads

23andMe had bad news about my health. I wish a person had delivered it

New case study details death in closely watched Alzhiemer's trial

entertainment

RaDonda Vaught case: a double standard for nurses, physicians

Emergency medicine has repudiated 'excited delirium.' Now what?

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

Pfizer's Covid pill remains 89% effective in final analysis, company says

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

Doctor appointment wait times are getting worse

focus

entertainment

entertainment

Wikipedia